Inhibiting oestrogen signalling in pulmonary arterial hypertension: sex, drugs and research
- PMID: 28775051
- DOI: 10.1183/13993003.00983-2017
Inhibiting oestrogen signalling in pulmonary arterial hypertension: sex, drugs and research
Conflict of interest statement
Conflict of interest: Disclosures can be found alongside this article at erj.ersjournals.com
Comment on
-
Oestrogen inhibition reverses pulmonary arterial hypertension and associated metabolic defects.Eur Respir J. 2017 Aug 3;50(2):1602337. doi: 10.1183/13993003.02337-2016. Print 2017 Aug. Eur Respir J. 2017. PMID: 28775043 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical